SPOTLIGHT -
Exploring Checkpoint Inhibition in Endometrial Cancers
Amanda Ramos, MD, a first-year fellow at the Massachusetts General Hospital in Boston, discusses the future potential of checkpoint inhibition therapy in the treatment of patients with recurrent endometrial cancers.
